Kazaks, A;
Lu, I-N;
Farinelle, S;
Ramirez, A;
Crescente, V;
Blaha, B;
Ogonah, O;
... Rosenberg, WM; + view all
(2017)
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
BMC Biotechnology
, 17
(1)
, Article 79. 10.1186/s12896-017-0396-8.
Preview |
Text
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.pdf - Published Version Download (2MB) | Preview |
Abstract
BACKGROUND: The lack of a universal influenza vaccine is a global health problem. Interest is now focused on structurally conserved protein domains capable of eliciting protection against a broad range of influenza virus strains. The long alpha helix (LAH) is an attractive vaccine component since it is one of the most conserved influenza hemagglutinin (HA) stalk regions. For an improved immune response, the LAH domain from H3N2 strain has been incorporated into virus-like particles (VLPs) derived from hepatitis B virus core protein (HBc) using recently developed tandem core technology. RESULTS: Fermentation conditions for recombinant HBc-LAH were established in yeast Pichia pastoris and a rapid and efficient purification method for chimeric VLPs was developed to match the requirements for industrial scale-up. Purified VLPs induced strong antibody responses against both group 1 and group 2 HA proteins in mice. CONCLUSION: Our results indicate that the tandem core technology is a useful tool for incorporation of highly hydrophobic LAH domain into HBc VLPs. Chimeric VLPs can be successfully produced in bioreactor using yeast expression system. Immunologic data indicate that HBc VLPs carrying the LAH antigen represent a promising universal influenza vaccine component.
Type: | Article |
---|---|
Title: | Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s12896-017-0396-8 |
Publisher version: | http://dx.doi.org/10.1186/s12896-017-0396-8 |
Language: | English |
Additional information: | © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | Influenza vaccine, Long alpha helix, Tandem-core, Virus-like particles, Yeast |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science |
URI: | https://discovery.ucl.ac.uk/id/eprint/10038897 |




Archive Staff Only
![]() |
View Item |